AI in Managed Care: UnitedHealth Group's Strategic Advancement

UnitedHealth Group Inc. is recognized as a leading advocate of artificial intelligence (AI) in the managed care industry, as per a recent report by Morgan Stanley. Following a comprehensive investor note, Morgan Stanley raised its price target for UnitedHealth to $453 from $395, maintaining its Overweight rating.

According to Morgan Stanley analyst Erin Wright, AI adoption presents significant opportunities for revenue and operational improvements within healthcare processes. Wright highlighted two major trends impacting managed care: a moderation in utilization trends supporting share performance, and AI technologies driving revenue growth and cost efficiency. This integration is estimated to boost average earnings per share by 45% as efficiency measures take full effect.

The report stresses that AI's influence in healthcare has transitioned from experimental stages to a vital role in core operations within managed care. The industry stands to benefit greatly from AI, given its extensive, sensitive data and traditionally labor-intensive processes.

AI is expected not only to reduce operational costs but also to improve medical loss ratios and create new revenue streams through AI-enabled services. UnitedHealth has actively promoted these technological advancements.

While focusing on insurance divisions, Morgan Stanley acknowledges potential benefits from areas like pharmacy benefit management and specialty pharmacy but emphasizes that savings might be reinvested rather than immediately boosting earnings. UnitedHealth and CVS Health Corp. are noted for redirecting savings into operations.

Additionally, the enhanced operational platform of UnitedHealth allows for adjustments to Medicare Advantage offerings to drive profit enhancements. Morgan Stanley also noted ongoing restructuring within Optum Health, anticipating significant progress by 2026.

As of the report, UnitedHealth Group's shares increased by 0.46%, reaching $398.30, close to its 52-week high of $404.15, as per Benzinga Pro data.